Moreover, it indicated that LIN28A enhanced drug resistance of AML cells to Ara-C, but CENPE interference reversed LIN28A-regulated Ara-C resistance in leukemic cells. The gene discussed is LIN28A; the disease is acute myeloid leukemia.